Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Return on Equity (2016 - 2025)

Capricor Therapeutics has reported Return on Equity over the past 15 years, most recently at 0.52% for Q4 2025.

  • Quarterly results put Return on Equity at 0.52% for Q4 2025, down 15.0% from a year ago — trailing twelve months through Dec 2025 was 0.52% (down 15.0% YoY), and the annual figure for FY2025 was 0.47%, up 2.0%.
  • Return on Equity for Q4 2025 was 0.52% at Capricor Therapeutics, up from 0.87% in the prior quarter.
  • Over the last five years, Return on Equity for CAPR hit a ceiling of 0.38% in Q4 2024 and a floor of 61.91% in Q3 2023.
  • Median Return on Equity over the past 5 years was 0.86% (2024), compared with a mean of 4.43%.
  • Biggest five-year swings in Return on Equity: plummeted -6028bps in 2023 and later surged 6105bps in 2024.
  • Capricor Therapeutics' Return on Equity stood at 0.61% in 2021, then crashed by -250bps to 2.14% in 2022, then fell by 0bps to 2.15% in 2023, then surged by 82bps to 0.38% in 2024, then tumbled by -38bps to 0.52% in 2025.
  • The last three reported values for Return on Equity were 0.52% (Q4 2025), 0.87% (Q3 2025), and 0.6% (Q2 2025) per Business Quant data.